
Razosin ER5 mg
Popular Pharmaceuticals Ltd.
Prazosin Hydrochloride is an alpha-1 adrenergic receptor antagonist used mainly for blood pressure control, with additional guideline-supported and off-label uses described below.
Prazosin Hydrochloride is an alpha-1 adrenergic receptor antagonist used mainly for blood pressure control, with additional guideline-supported and off-label uses described below.
Trauma-related nightmares in post-traumatic stress disorder (PTSD) – Prazosin Hydrochloride has been used off-label, at bedtime, to reduce nightmares and improve sleep in patients with PTSD. Earlier controlled trials and some clinical guidelines supported this use; however, a large randomized trial found no significant benefit over placebo, so current guidance is mixed. Any use of Prazosin Hydrochloride for this purpose should be individualized and supervised by a physician.
The dose of Prazosin Hydrochloride must be individualized by indication and titrated slowly to minimize the risk of first-dose orthostatic hypotension and syncope. The very first dose of Prazosin Hydrochloride should be small (commonly 0.5–1 mg) and taken at bedtime, with the patient advised to avoid activities requiring alertness (e.g. driving) for several hours after the first dose or any dose increase.
| Step | Dose | Notes |
|---|---|---|
| Initial (first dose) | 0.5–1 mg, taken at bedtime | Minimizes first-dose syncope/orthostatic hypotension risk |
| Early titration | 1 mg two or three times daily | Continue for several days before further increases |
| Maintenance | Usually 6–15 mg/day in divided doses | Maximum 20 mg/day (immediate-release) |
| Extended-release | Start 2.5 mg once daily; increase gradually | Maximum 20 mg once daily |
| Adding a diuretic/other antihypertensive | Reduce Prazosin Hydrochloride to 1–2 mg three times daily | Then re-titrate under medical supervision |
Initial 0.5 mg twice daily, increased gradually as tolerated to a usual maintenance of 1–2 mg twice daily (up to 2 mg three times daily in some patients), under physician guidance.
Initial 0.5 mg twice daily, increased as needed to a usual maintenance of about 2 mg twice daily (maximum around 4 mg/day), with blood pressure monitored given the risk of hypotension, especially in elderly patients.
Typically initiated at 1 mg at bedtime and titrated slowly over weeks under psychiatric/medical supervision, based on response and tolerability; there is no single universally agreed dose, and response to Prazosin Hydrochloride for this use varies between patients.
Adverse effects of Prazosin Hydrochloride are generally dose-related and most prominent at the start of therapy or after a dose increase.
Prazosin Hydrochloride is contraindicated in:
No other well-established absolute contraindications exist; conditions requiring caution (e.g. concurrent PDE5 inhibitor use, planned cataract surgery, hepatic impairment) are discussed under Precautions and Warnings rather than as absolute contraindications.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.